MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Cepheid Company Profile (NASDAQ:CPHD)

Consensus Ratings for Cepheid (NASDAQ:CPHD) (?)
Ratings Breakdown: 1 Sell Rating(s), 8 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Buy (Score: 2.55)
Consensus Price Target: $42.18 (45.11% upside)

Analysts' Ratings History for Cepheid (NASDAQ:CPHD)
Show:
DateFirmActionRatingPrice TargetActions
6/15/2016Morgan StanleyInitiated CoverageEqual Weight$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Needham & Company LLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Atlantic SecuritiesUpgradeNeutral -> OverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016BTIG ResearchUpgradeNeutral -> Buy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016WedbushLower Price TargetOutperform$58.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Robert W. BairdLower Price TargetOutperform$45.00 -> $40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Stifel NicolausLower Price TargetBuy$42.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016BarclaysLower Price TargetEqual Weight$38.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Leerink SwannReiterated RatingMarket Perform$39.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016Avondale PartnersInitiated CoverageOutperform$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/2/2015Wells FargoDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Craig HallumLower Price TargetBuy$52.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Evercore ISIUpgradeSell -> Hold$44.50 -> $32.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015MizuhoLower Price TargetBuy$60.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/15/2015Citigroup Inc.Lower Price TargetBuy$62.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Piper JaffrayReiterated RatingBuy$66.00 -> $62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Jefferies GroupLower Price TargetHold$55.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Goldman SachsLower Price Target$53.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Raymond JamesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/26/2015MKM PartnersReiterated RatingBuy$65.00 -> $72.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2015Evercore Partners Inc.Reiterated RatingHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2015Cantor FitzgeraldReiterated RatingBuy$62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/24/2015JMP SecuritiesBoost Price TargetMarket Outperform$58.00 -> $67.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015OppenheimerBoost Price TargetOutperform$57.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Bank of AmericaUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014S&P Equity ResearchBoost Price TargetAverage -> Hold$6.58 -> $8.30View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Cepheid (NASDAQ:CPHD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/21/2016        
4/28/2016Q116$0.01$0.08$140.35 million$144.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2016Q415($0.20)$0.07$146.95 million$147.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2015Q3($0.31)($0.13)$126.81 million$126.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2015Q215($0.21)($0.06)$130.70 million$132.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2015Q115($0.16)$0.01$125.50 million$132.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414($0.13)$0.11$125.34 million$131.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/16/2014Q314($0.16)$0.06$110.10 million$115.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/17/2014Q214($0.13)$0.03$115.47 million$116.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/17/2014Q114($0.17)($0.01)$104.90 million$106.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q413($0.11)($0.15)$102.17 million$113.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/17/2013Q313($0.11)($0.20)$93.70 million$100.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2013Q2 2013$0.04$0.02$92.57 million$96.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/18/2013Q1 2013$0.10$0.11$89.12 million$91.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/24/2013Q4 2012$0.11$0.20$92.87 million$92.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2012($0.07)($0.32)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2012$0.11$0.11ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2012($0.01)($0.08)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012($0.02)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2011$0.02$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2011($0.01)$0.03ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/20/2011($0.01)$0.01ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011($0.02)$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Cepheid (NASDAQ:CPHD)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.16)($0.21)
Q2 20163($0.20)($0.17)($0.18)
Q3 20163($0.18)($0.11)($0.15)
Q4 20162($0.03)($0.01)($0.02)
(Data provided by Zacks Investment Research)
Dividend History for Cepheid (NASDAQ:CPHD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cepheid (NASDAQ:CPHD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/3/2016Scott A CampbellVPSell2,058$27.90$57,418.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/2/2016Peter V FarrellEVPSell390$28.90$11,271.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2016Peter V FarrellEVPSell390$36.30$14,157.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2016John L BishopCEOSell110,000$35.50$3,905,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2016Peter V FarrellEVPSell393$33.01$12,972.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Warren C. Kocmond, Jr.COOSell292$28.53$8,330.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/1/2016Warren C. Kocmond, Jr.COOSell351$28.44$9,982.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2016Warren C. Kocmond, Jr.COOSell157$33.16$5,206.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Peter V. FarrellEVPSell394$31.67$12,477.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2015Robert J EastonDirectorSell3,206$36.02$115,480.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2015Robert J EastonDirectorSell2,724$34.84$94,904.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Robert J EastonDirectorSell2,556$35.01$89,485.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015Peter V. FarrellEVPSell1,560$33.89$52,868.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2015Peter V. FarrellEVPSell1,577$48.67$76,752.59View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Cristina KepnerDirectorBuy10,000$47.78$477,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/26/2015Warren C Kocmond JrCOOSell9,375$61.52$576,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Thomas L GutshallDirectorSell1,800$56.62$101,916.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2015Joseph H SmithEVPSell91,866$54.51$5,007,615.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/20/2015John L BishopCEOSell100,000$55.20$5,520,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2015Hollings RentonDirectorSell9,375$57.76$541,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Dean O MortonDirectorSell12,500$58.51$731,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Thomas D BrownDirectorSell12,500$56.29$703,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2015Andrew MillerCFOSell6,677$57.64$384,862.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Andrew MillerCFOSell11,719$56.65$663,881.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015David H PersingEVPSell5,000$56.90$284,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Warren C Kocmond JrCOOSell4,688$57.00$267,216.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Andrew MillerCFOSell2,250$54.95$123,637.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Kerry FlomEVPSell8,694$54.21$471,301.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2014Dean O MortonDirectorSell11,849$52.96$627,523.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Hollings RentonDirectorSell9,375$51.07$478,781.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Andrew MillerCFOSell12,167$53.84$655,071.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014David H PersingEVPSell20,000$53.34$1,066,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Dean O MortonDirectorSell7,500$52.64$394,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Kerry FlomEVPSell7,077$51.36$363,474.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2014Thomas L GutshallDirectorSell12,500$51.63$645,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014David H PersingEVPSell15,000$51.51$772,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Kerry FlomEVPSell1,271$44.52$56,584.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Warren C Kocmond JrEVPSell324$38.69$12,535.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2014Kerry FlomEVPSell2,812$49.72$139,812.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/3/2014Kerry FlomEVPSell1,282$48.97$62,779.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Kerry FlomEVPSell4,265$45.49$194,014.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2014Warren C Kocmond JrEVPSell1,300$42.38$55,094.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014Kerry FlomEVPSell2,660$42.38$112,730.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2014John BishopCEOSell107,651$43.93$4,729,108.43View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2014John BishopCEOSell42,349$46.11$1,952,712.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2014Robert EastonDirectorSell12,500$45.59$569,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2014Kerry FlomEVPSell1,621$51.55$83,562.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2014Andrew MillerCFOSell4,688$52.78$247,432.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2014Andrew MillerCFOSell17,265$55.55$959,070.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Andrew MillerCFOSell63,375$53.10$3,365,212.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014John BishopCEOSell150,000$50.67$7,600,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Joseph SmithEVPSell50,000$51.15$2,557,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014Kerry FlomEVPSell6,357$45.66$290,260.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Andrew MillerCFOSell2,437$45.92$111,907.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/23/2013Kerry FlomEVPSell10,000$46.51$465,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013David H PersingVPSell5,000$41.35$206,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Kerry FlomEVPSell2,660$40.50$107,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013Thomas L GutshallDirectorSell3,000$40.07$120,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/18/2013David H PersingVPSell20,000$40.59$811,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2013Thomas GutshallDirectorSell3,000$38.97$116,910.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013David PersingVPSell5,000$39.34$196,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013David PersingVPSell5,000$38.95$194,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2013David H PersingVPSell20,000$37.99$759,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013David PersingVPSell5,129$36.62$187,823.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Thomas GutshallDirectorSell3,000$36.38$109,140.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2013Robert EastonDirectorSell7,500$35.01$262,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2013Thomas L GutshallDirectorSell3,000$34.18$102,540.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2013Thomas L GutshallDirectorSell3,000$32.91$98,730.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Andrew MillerCFOSell22,468$38.51$865,242.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Thomas L GutshallDirectorSell3,000$37.90$113,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Kerry FlomEVPSell6,832$39.76$271,640.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2013Thomas L GutshallDirectorSell3,000$38.28$114,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Joseph H SmithEVPSell38,400$36.20$1,390,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2012Thomas L GutshallDirectorSell3,000$33.06$99,180.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Thomas L GutshallDirectorSell7,778$31.94$248,429.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Cepheid (NASDAQ:CPHD)
DateHeadline
06/25/16 07:14 AMResMed (RMD), St. Jude (STJ), Cepheid (CPHD) Among Med Tech Companies with Most EU Exposure - Needham ... - StreetInsider.com
06/23/16 08:48 PMNew Broker Ratings For CEPHEID (NASDAQ:CPHD) - FTSE News
06/22/16 08:04 AMRecently Issued Stock Ratings For CEPHEID (NASDAQ:CPHD) - Fiscal Standard
06/21/16 07:08 AMCepheid breached its 50 day moving average in a Bullish Manner : CPHD-US : June 21, 2016 -
06/20/16 09:41 AMStock Buzz: Cepheid (NASDAQ:CPHD) - iStreetWire
06/18/16 03:08 PMShares of CEPHEID (NASDAQ:CPHD) Sees Large Outflow of Money - Trade Calls
06/18/16 07:58 AMHealthcare ratings roundup - new coverage
06/17/16 10:47 AMUpcoming Earnings Report: Cepheid (NASDAQ:CPHD) - iStreetWire
06/16/16 03:21 PMCepheid Margin Expansion Unlikely To Morgan Stanley, Stays On Sidelines
06/16/16 07:45 AMMorgan Stanley Begins Coverage on CEPHEID (CPHD) Giving It An Initial Rating Of "Equal-weight" - Finance Daily
06/15/16 08:07 AMMorgan Stanley Begins Coverage on CEPHEID (CPHD) Giving It An Initial Rating Of “Equal-weight”
06/15/16 07:49 AMCepheid Announces World Health Organization Prequalification Of Xpert HIV-1 Qualitative Test - [at noodls] - SUNNYVALE, Calif., June 15, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that its Xpert® HIV-1 Qual (Qualitative) test has been awarded World Health Organization (WHO) prequalification, ...
06/15/16 07:32 AM8:32 am Cepheid's Xpert HIV-1 Qual (Qualitative) test has received World Health Organization prequalification -
06/10/16 09:21 PMWhy Investors Love These Scientific & Technical Instruments' Stocks? - Trimble Navigation, Garmin, Cepheid, and Keysight Technologies
06/09/16 09:22 PMCEPHEID (NASDAQ:CPHD) Low Price Is Set At $28 - RealistInvestor.com
06/09/16 08:42 AMCepheid (NASDAQ:CPHD) Fundamental Star Rating Report - CML News
06/06/16 03:12 PMCEPHEID (NASDAQ:CPHD) Financial Condition Compared to S&P 500 - CML News
06/06/16 06:17 AMCepheid Incorporated (NASDAQ:CPHD) Shorted Shares Increased 8.7% After Market Selling - HNN
06/04/16 11:41 AMHot on Yesterday? CEPHEID (NASDAQ:CPHD) , Orange (NYSE:ORAN) - Is stories
06/03/16 11:49 AMCepheid (NASDAQ:CPHD) Earnings Preview: Should Investors Be Nervous? - iStreetWire
06/01/16 09:32 PMStrong Sell Calls Count For CEPHEID (NASDAQ:CPHD) At 0 - Investor Newswire - Strong Sell Calls Count For CEPHEID (NASDAQ:CPHD) At 0Investor NewswireCEPHEID (NASDAQ:CPHD) has a total of 7 Strong Buy calls and 0 Strong Sell advises as of 2016-05-31. Zacks uses a rating procedure which assigns scores to stocks on a narrow 1-5 scale. When a stock gets a score of 1 or 2, it is considered to be a buy ...and more »
05/31/16 03:25 PMStock Review and Earnings Check on CEPHEID (NASDAQ:CPHD) - HNN - Stock Review and Earnings Check on CEPHEID (NASDAQ:CPHD)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting CEPHEID (NASDAQ:CPHD) to ...and more »
05/31/16 10:14 AMCEPHEID (NASDAQ:CPHD) Quarterly EPS Estimate At $0.02 - Investor Newswire - CEPHEID (NASDAQ:CPHD) Quarterly EPS Estimate At $0.02Investor NewswireFirst Call stated that CEPHEID (NASDAQ:CPHD) can touch $38.59 in coming one year. For the next quarter, the per-share earnings target is $0.02 and for ongoing fiscal at $0.21. EPS target for next year is $0.95 versus the mean EPS of $-0.77 last year.and more »
05/27/16 06:51 AMCepheid: GeneXpert Placements High, Currency Woes Stay -
05/24/16 12:57 PMInteresting CPHD Put And Call Options For July 15th - Investors in Cepheid (Symbol: CPHD) saw new options become available today, for the July 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CPHD options chain for the new July 15th contracts and identified one put ...
05/20/16 06:53 AMMarket Has Not Yet Noticed Potential in Cepheid (CPHD); Have You? -
05/18/16 09:22 PMETF’s with exposure to Cepheid : May 19, 2016 -
05/18/16 03:32 PMUS National TB Controllers Association And Association Of Public Health Laboratories Issue Guidance For Use Of Xpert MTB/RIF To Support Respiratory Isolation Decisions - [at noodls] - SUNNYVALE, Calif., May 18, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today welcomed publication of new guidance from the US National Tuberculosis Controllers Association (NTCA) and the Association of ...
05/17/16 01:18 PMKornitzer Capital Management INC Increased Cepheid (NASDAQ:CPHD) by $18.60 Million as Shares Declined - CCH Daily News - Kornitzer Capital Management INC Increased Cepheid (NASDAQ:CPHD) by $18.60 Million as Shares DeclinedCCH Daily NewsKornitzer Capital Management Inc increased its stake in Cepheid (NASDAQ:CPHD) by 85.64% based on its latest 2016Q1 regulatory filing with the SEC. Kornitzer Capital Management Inc bought 563,653 shares as the company's stock declined 8.33% while ...and more »
05/12/16 07:03 AMTwo Buzzers to Observe: CEPHEID (NASDAQ:CPHD) , Aspen Technology, Inc. (NASDAQ:AZPN) - Street Updates - Two Buzzers to Observe: CEPHEID (NASDAQ:CPHD) , Aspen Technology, Inc. (NASDAQ:AZPN)Street UpdatesOn 5/11/2016, shares of CEPHEID (NASDAQ:CPHD) rose +0.45% in trading session and finally closed at $26.82. The company most recent volume stood at 1.15 million shares as compared to its average volume of 792.27 thousand shares. Over the one year ...
05/11/16 12:04 PMCEPHEID Financials -
05/09/16 06:38 AMAfter Last Week What Do Analysts Think Of CEPHEID (NASDAQ:CPHD) - Share Trading News - After Last Week What Do Analysts Think Of CEPHEID (NASDAQ:CPHD)Share Trading News10/15/2015 – CEPHEID had its “buy” rating reiterated by analysts at Citigroup. They now have a USD 48 price target on the stock. The share price of CEPHEID (NASDAQ:CPHD) was down -1.27% during the last trading session, with a day high of 26.14.and more »
05/06/16 06:48 AMCEPHEID (CPHD) Drops 5.6% on May 04 - Equities.com - CEPHEID (CPHD) Drops 5.6% on May 04Equities.comCEPHEID (CPHD) was one of the Russell 2000's biggest losers for Wednesday May 04 as the stock slid 5.6% to $25.79, a loss of $-1.53 per share. Starting at an opening price of $27.22 a share, the stock traded between $25.43 and $27.24 over the course of ...and more »
05/05/16 11:10 AMCepheid :CPHD-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/05/16 07:00 AMUS National TB Controllers Association And Association Of Public Health Laboratories Recommend Using Xpert MTB/RIF To Support Respiratory Isolation Decisions - [PR Newswire] - SUNNYVALE, Calif., May 5, 2016 /PRNewswire/ -- Cepheid (CPHD) today welcomed publication of new recommendations from the US National Tuberculosis Controllers Association (NTCA) and the Association of Public Health Laboratories (APHL) on the use of Xpert MTB/RIF to support decision-making on using Airborne Infection Isolation (AII), commonly referred to as respiratory isolation, in healthcare settings. Cepheid's Xpert MTB/RIF test received FDA clearance for expanded claims relating to respiratory isolation in February 2015, but this is the first formal set of recommendations by NTCA and APHL on using Xpert MTB/RIF.
05/05/16 06:41 AMCEPHEID (NASDAQ:CPHD): EVP, Worldwide Commercial Ops Farrell Peter V. sells 390 shares - According to CEPHEID's most recent Form 4 filing with the SEC dated May 03 05:19 PM, company EVP, Worldwide Commercial Ops, Farrell Peter V. disclosed selling 390 shares at a cost of $28.90. At the time of this transaction (May 02), this trade was worth $ ...
05/04/16 03:46 PMCEPHEID Files SEC form 10-Q, Quarterly Report -
05/03/16 12:48 PMETF’s with exposure to Cepheid : May 3, 2016 -
05/03/16 07:20 AMCepheid to Webcast Upcoming Financial Presentations - [at noodls] - SUNNYVALE, Calif., May 3, 2016 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via webcast. ...
05/03/16 06:24 AMToday's Dead Cat Bounce Stock: Cepheid (CPHD) - TheStreet.com - Hot Stocks PointToday's Dead Cat Bounce Stock: Cepheid (CPHD)TheStreet.comThe average volume for Cepheid has been 929,300 shares per day over the past 30 days. Cepheid has a market cap of $2.7 billion and is part of the technology sector and electronics industry. The stock has a beta of 0.35 and a short float of 5.9% with 5 ...Cepheid (CPHD) Analysts Recommendations and Insider TradingZergwatchAnalyst Review: CEPHEID (NASDAQ:CPHD)Risers & FallersEye Catching Insider Selling: Cepheid (NASDAQ:CPHD)The Point ReviewFranklin Independent -Hot Stocks Point -Investor Newswireall 8 news articles »
05/02/16 07:10 AMCepheid breached its 50 day moving average in a Bearish Manner : CPHD-US : May 2, 2016 -
05/02/16 06:31 AMCEPHEID (NASDAQ:CPHD) Broker Price Targets For The Coming Week - Share Trading News - CEPHEID (NASDAQ:CPHD) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of CEPHEID (NASDAQ:CPHD). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts ...and more »
04/29/16 10:31 AMCepheid (CPHD) Q1 Loss Narrower than Expected, Sales Top -
04/29/16 07:12 AMCepheid (CPHD) Tops Q1 EPS by 7c, Offers FY Guidance - StreetInsider.com - Cepheid (CPHD) Tops Q1 EPS by 7c, Offers FY GuidanceStreetInsider.comCepheid (NASDAQ: CPHD) reported Q1 EPS of $0.08, $0.07 better than the analyst estimate of $0.01. Revenue for the quarter came in at $144.8 million versus the consensus estimate of $140.35 million. GUIDANCE: Cepheid sees FY2016 EPS of ...and more »
04/29/16 07:12 AMCepheid (CPHD) John L. Bishop on Q1 2016 Results - Earnings Call Transcript - Seeking Alpha - CWRU ObserverCepheid (CPHD) John L. Bishop on Q1 2016 Results - Earnings Call TranscriptSeeking AlphaGood day, ladies and gentlemen, and welcome to Cepheid's First Quarter 2016 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session and instructions will be given at that time.Analysts Review on Trending Stock: Cepheid (CPHD)CWRU ObserverCepheid (CPHD) Releases FY16 Earnings GuidanceWeb Breaking NewsCepheid (CPHD) Profit Expected to DeclineThe PostB.O.D.Y Confidential -Risers & Fallers -Finance Dailyall 15 news articles »
04/28/16 09:51 PMEdited Transcript of CPHD earnings conference call or presentation 28-Apr-16 9:00pm GMT -
04/28/16 05:11 PMCepheid reports 1Q loss - [AP] - The Sunnyvale, California-based company said it had a loss of 9 cents per share. Earnings, adjusted for stock option expense and amortization costs, were 8 cents per share. The results exceeded Wall Street ...
04/28/16 03:35 PMCEPHEID Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
04/28/16 03:15 PMCepheid Reports First Quarter 2016 Results - [at noodls] - SUNNYVALE, Calif., April 28, 2016 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today reported revenue for the first quarter of 2016 of $144.8 million, representing growth of 9%, or 13% on a constant currency ...
04/28/16 06:42 AMCEPHEID (NASDAQ:CPHD) Share Rating Recap - The Post - CEPHEID (NASDAQ:CPHD) Share Rating RecapThe PostShares of CEPHEID (NASDAQ:CPHD) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from financial ...and more »
About Cepheid

Cepheid logoCepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: Scientific & Technical Instruments
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: CPHD
  • CUSIP: 15670R10
Key Metrics:
  • Previous Close: $29.07
  • 50 Day Moving Average: $27.92
  • 200 Day Moving Average: $31.26
  • P/E Ratio: N/A
  • P/E Growth: 5.81
  • Market Cap: $2.12B
  • Current Quarter EPS Consensus Estimate: $0.25 EPS
Additional Links:
Cepheid (NASDAQ:CPHD) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha